More on BSEM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $5.49 |
|
|||
| Open | $5.49 | ||||
| 52 Wk High | $23.00 | ||||
| 52 Wk Low | $4.50 | ||||
| Day High | $5.71 | ||||
| Day Low | $5.16 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 62,637 | ||||
- BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference
- BioStem Technologies notes FDA support for bayesian trial methods
- BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research
- BioTissue Holdings, Inc Strengthens Strategic Focus on Ocular Innovation with Sale of Surgical and Wound Care Business to BioStem Technologies
- BioStem Technologies acquires BioTissue wound care business for $15 million
- BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings’ Surgical and Wound Care Business
- BioStem Technologies comments on CMS rule withdrawal for wound products
- BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes
- BioStem Technologies Products Placed on “12-Month Status Quo Period” List in Update to CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes
- BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference
Entities mentioned with BSEM
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- S1 | View Related Stories »
- Show More...
